{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T08:58:03Z","timestamp":1791622683684,"version":"4.3.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T00:00:00Z","timestamp":1508716800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100011963","name":"European Academy of Neurology","doi-asserted-by":"crossref","award":["research fellowship"],"award-info":[{"award-number":["research fellowship"]}],"id":[{"id":"10.13039\/501100011963","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Austrian Federal Ministry of Science and Economy","award":["grant BIG WIG MS"],"award-info":[{"award-number":["grant BIG WIG MS"]}]},{"name":"Austrian Research promotion Agency FFG, Bridge 1","award":["853209 EDNA"],"award-info":[{"award-number":["853209 EDNA"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s00415-017-8635-4","type":"journal-article","created":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T21:22:00Z","timestamp":1508793720000},"page":"2420-2430","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":149,"title":["Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study"],"prefix":"10.1007","volume":"264","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7806-3103","authenticated-orcid":false,"given":"Sara","family":"Mariotto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Monaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Donata","family":"Benedetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Schanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Alberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Farinazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruggero","family":"Capra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Mancinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"De Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Bombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Zuliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Zoccarato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Tanel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Bonora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Turatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Calabrese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Polo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Pavone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Grazian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GianPietro","family":"Sechi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elia","family":"Sechi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Urso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachele","family":"Delogu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Janes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"Deotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morena","family":"Cadaldini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rachele","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Cantalupo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Reindl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Gajofatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,23]]},"reference":[{"key":"8635_CR1","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","volume":"364","author":"VA Lennon","year":"2004","unstructured":"Lennon VA, Wingerchuk DM, Kryzer TJ et al (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364:2106\u20132112","journal-title":"Lancet"},{"key":"8635_CR2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","volume":"202","author":"VA Lennon","year":"2005","unstructured":"Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR (2005) IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202:473\u2013477","journal-title":"J Exp Med"},{"key":"8635_CR3","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrneurol.2010.72","volume":"6","author":"S Jarius","year":"2010","unstructured":"Jarius S, Wildemann B (2010) AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance. Nat Rev Neurol 6:383\u2013392","journal-title":"Nat Rev Neurol"},{"key":"8635_CR4","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1212\/WNL.0b013e3182a6cb5c","volume":"81","author":"Y Jiao","year":"2013","unstructured":"Jiao Y, Fryer JP, Lennon VA et al (2013) Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica. Neurology 81:1197\u201311204","journal-title":"Neurology"},{"key":"8635_CR5","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1212\/WNL.0b013e318248dec1","volume":"78","author":"PJ Waters","year":"2012","unstructured":"Waters PJ, McKeon A, Leite MI et al (2012) Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. Neurology 78:665\u2013671","journal-title":"Neurology"},{"key":"8635_CR6","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1212\/WNL.0b013e318296e917","volume":"80","author":"R Marignier","year":"2013","unstructured":"Marignier R, Bernard-Valnet R, Giraudon P, NOMADMUS Study Group et al (2013) Aquaporin-4 antibody-negative neuromyelitis optica: distinct assay sensitivity-dependent entity. Neurology 80:2194\u20132200","journal-title":"Neurology"},{"key":"8635_CR7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL, International Panel for NMO Diagnosis et al (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85:177\u2013189","journal-title":"Neurology"},{"key":"8635_CR8","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/ana.21916","volume":"66","author":"F Brilot","year":"2009","unstructured":"Brilot F, Dale RC, Selter RC et al (2009) Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease. Ann Neurol 66:833\u2013842","journal-title":"Ann Neurol"},{"key":"8635_CR9","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1001\/archneurol.2011.2956","volume":"69","author":"K Rostasy","year":"2012","unstructured":"Rostasy K, Mader S, Schanda K et al (2012) Anti-myelin oligodendrocyte glycoprotein antibodies in pediatric patients with optic neuritis. Arch Neurol 69:752\u2013756","journal-title":"Arch Neurol"},{"key":"8635_CR10","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.4049\/jimmunol.0801888","volume":"183","author":"KA McLaughlin","year":"2009","unstructured":"McLaughlin KA, Chitnis T, Newcombe J et al (2009) Age-dependent B cell autoimmunity to a myelin surface antigen in pediatric multiple sclerosis. J Immunol 183:4067\u20134076","journal-title":"J Immunol"},{"key":"8635_CR11","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000004312","author":"EM Hennes","year":"2017","unstructured":"Hennes EM, Baumann M, Schanda K et al (2017) Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome. Neurology. doi:\n                        10.1212\/WNL.0000000000004312","journal-title":"Neurology"},{"key":"8635_CR12","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/1742-2094-8-184","volume":"8","author":"S Mader","year":"2011","unstructured":"Mader S, Gredler V, Schanda K et al (2011) Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders. J Neuroinflammation 8:184","journal-title":"J Neuroinflammation"},{"key":"8635_CR13","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1212\/WNL.0b013e318228c0b1","volume":"77","author":"AK Pr\u00f6bstel","year":"2011","unstructured":"Pr\u00f6bstel AK, Dornmair K, Bittner R et al (2011) Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis. Neurology 77:580\u2013588","journal-title":"Neurology"},{"key":"8635_CR14","doi-asserted-by":"crossref","first-page":"19057","DOI":"10.1073\/pnas.0607242103","volume":"103","author":"D Zhou","year":"2006","unstructured":"Zhou D, Srivastava R, Nessler S et al (2006) Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis. Proc Natl Acad Sci USA 103:19057\u201319062","journal-title":"Proc Natl Acad Sci USA"},{"key":"8635_CR15","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1212\/WNL.0b013e31826aac4e","volume":"79","author":"J Kitley","year":"2012","unstructured":"Kitley J, Woodhall M, Waters P et al (2012) Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype. Neurology 79:1273\u20131277","journal-title":"Neurology"},{"key":"8635_CR16","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1001\/jamaneurol.2013.5857","volume":"71","author":"J Kitley","year":"2014","unstructured":"Kitley J, Waters P, Woodhall M et al (2014) Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study. JAMA Neurol 71:276\u2013283","journal-title":"JAMA Neurol"},{"key":"8635_CR17","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1212\/WNL.0000000000000101","volume":"82","author":"DK Sato","year":"2014","unstructured":"Sato DK, Callegaro D, Lana-Peixoto MA et al (2014) Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology 82:474\u2013481","journal-title":"Neurology"},{"key":"8635_CR18","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/acn3.164","volume":"2","author":"M Spadaro","year":"2015","unstructured":"Spadaro M, Gerdes LA, Mayer MC et al (2015) Histopathology and clinical course of MOG-antibody-associated encephalomyelitis. Ann Clin Transl Neurol 2:295\u2013301","journal-title":"Ann Clin Transl Neurol"},{"key":"8635_CR19","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1212\/NXI.0000000000000089","volume":"2","author":"P Waters","year":"2015","unstructured":"Waters P, Woodhall M, O\u2019Connor KC et al (2015) MOG cell-based assay detects non-MS patients with inflammatory neurologic disease. Neurol Neuroimmunol Neuroinflamm 2:e89","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"8635_CR20","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12974-015-0256-1","volume":"12","author":"AK Pr\u00f6bstel","year":"2015","unstructured":"Pr\u00f6bstel AK, Rudolf G, Dornmair K et al (2015) Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype. J Neuroinflammation 12:46","journal-title":"J Neuroinflammation"},{"key":"8635_CR21","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1177\/1352458515587751","volume":"22","author":"C Fernandez-Carbonell","year":"2016","unstructured":"Fernandez-Carbonell C, Vargas-Lowy D, Musallam A, Healy B, McLaughlin K, Wucherpfennig KW, Chitnis T (2016) Clinical and MRI phenotype of children with MOG antibodies. Mult Scler 22:174\u2013184","journal-title":"Mult Scler"},{"key":"8635_CR22","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1177\/1352458516631038","volume":"22","author":"M Baumann","year":"2016","unstructured":"Baumann M, Hennes EM, Schanda K et al (2016) Children with multiphasic disseminated encephalomyelitis and antibodies to the myelin oligodendrocyte glycoprotein (MOG): extending the spectrum of MOG antibody positive diseases. Mult Scler 22:1821\u20131829","journal-title":"Mult Scler"},{"key":"8635_CR23","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1007\/s11427-015-4997-y","volume":"59","author":"Y Yan","year":"2016","unstructured":"Yan Y, Li Y, Fu Y et al (2016) Autoantibody to MOG suggests two distinct clinical subtypes of NMOSD. Sci China Life Sci 59:1270\u20131281","journal-title":"Sci China Life Sci"},{"key":"8635_CR24","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/ene.12898","volume":"23","author":"ED Pelt van","year":"2016","unstructured":"van Pelt ED, Wong YY, Ketelslegers IA, Hamann D, Hintzen RQ (2016) Neuromyelitis optica spectrum disorders: comparison of clinical and magnetic resonance imaging characteristics of AQP4-IgG versus MOG-IgG seropositive cases in The Netherlands. Eur J Neurol 23:580\u2013587","journal-title":"Eur J Neurol"},{"key":"8635_CR25","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1177\/1352458515614093","volume":"22","author":"S Siritho","year":"2016","unstructured":"Siritho S, Sato DK, Kaneko K, Fujihara K, Prayoonwiwat N (2016) The clinical spectrum associated with myelin oligodendrocyte glycoprotein antibodies (anti-MOG-Ab) in Thai patients. Mult Scler 22:964\u2013968","journal-title":"Mult Scler"},{"key":"8635_CR26","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s00415-016-8147-7","volume":"263","author":"M Sep\u00falveda","year":"2016","unstructured":"Sep\u00falveda M, Armangue T, Martinez-Hernandez E et al (2016) Clinical spectrum associated with MOG autoimmunity in adults: significance of sharing rodent MOG epitopes. J Neurol 263:1349\u20131360","journal-title":"J Neurol"},{"key":"8635_CR27","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1212\/NXI.0000000000000257","volume":"3","author":"M Spadaro","year":"2016","unstructured":"Spadaro M, Gerdes LA, Krumbholz M et al (2016) Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis. Neurol Neuroimmunol Neuroinflamm 3:e257","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"8635_CR28","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/jnnp-2015-311743","volume":"87","author":"C Lechner","year":"2016","unstructured":"Lechner C, Baumann M, Hennes EM et al (2016) Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the disease. J Neurol Neurosurg Psychiatry 87:897\u2013905","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8635_CR29","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s12974-016-0717-1","volume":"13","author":"S Jarius","year":"2016","unstructured":"Jarius S, Ruprecht K, Kleiter I, In cooperation with the Neuromyelitis Optica Study Group (NEMOS) et al (2016) MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin. J Neuroinflammation 13:279","journal-title":"J Neuroinflammation"},{"key":"8635_CR30","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12974-016-0718-0","volume":"13","author":"S Jarius","year":"2016","unstructured":"Jarius S, Ruprecht K, Kleiter I, In cooperation with the Neuromyelitis Optica Study Group (NEMOS) et al (2016) MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. J Neuroinflammation 13:280","journal-title":"J Neuroinflammation"},{"key":"8635_CR31","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1212\/WNL.0000000000004117","volume":"89","author":"Y Hacohen","year":"2017","unstructured":"Hacohen Y, Mankad K, Chong WK et al (2017) Diagnostic algorithm for relapsing acquired demyelinating syndromes in children. Neurology 89:269\u2013278","journal-title":"Neurology"},{"key":"8635_CR32","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/ene.13315","volume":"24","author":"R Deschamps","year":"2017","unstructured":"Deschamps R, Lecler A, Lamirel C et al (2017) Etiologies of acute demyelinating optic neuritis: an observational study of 110 patients. Eur J Neurol 24:875\u2013879","journal-title":"Eur J Neurol"},{"key":"8635_CR33","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/WCO.0000000000000446","volume":"30","author":"M Reindl","year":"2017","unstructured":"Reindl M, Jarius S, Rostasy K, Berger T (2017) Myelin oligodendrocyte glycoprotein antibodies: how clinically useful are they? Curr Opin Neurol 30:295\u2013301","journal-title":"Curr Opin Neurol"},{"key":"8635_CR34","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B et al (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69:292\u2013302","journal-title":"Ann Neurol"},{"key":"8635_CR35","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","volume":"83","author":"FD Lublin","year":"2014","unstructured":"Lublin FD, Reingold SC, Cohen JA et al (2014) Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology 83:278\u2013286","journal-title":"Neurology"},{"key":"8635_CR36","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/brain\/awg045","volume":"126","author":"D Kidd","year":"2003","unstructured":"Kidd D, Burton B, Plant GT, Graham EM (2003) Chronic relapsing inflammatory optic neuropathy (CRION). Brain 126:276\u2013284","journal-title":"Brain"},{"key":"8635_CR37","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.autrev.2014.01.009","volume":"13","author":"A Petzold","year":"2014","unstructured":"Petzold A, Plant GT (2014) Diagnosis and classification of autoimmune optic neuropathy. Autoimmun Rev 13:539\u2013545","journal-title":"Autoimmun Rev"},{"key":"8635_CR38","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1177\/1352458513484547","volume":"19","author":"LB Krupp","year":"2013","unstructured":"Krupp LB, Tardieu M, Amato MP et al (2013) International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler 19:1261\u20131267","journal-title":"Mult Scler"},{"key":"8635_CR39","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/jnnp.57.8.897","volume":"57","author":"M Andersson","year":"1994","unstructured":"Andersson M, Bernardi Alvarez-Cerme\u00f1o J et al (1994) Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg Psychiatry 57:897\u2013902","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8635_CR40","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.clim.2010.11.013","volume":"138","author":"F Pauli Di","year":"2011","unstructured":"Di Pauli F, Mader S, Rostasy K et al (2011) Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases. Clin Immunol 138:247\u2013254","journal-title":"Clin Immunol"},{"key":"8635_CR41","first-page":"205521731667563","volume":"2","author":"L Pandit","year":"2016","unstructured":"Pandit L, Sato DK, Mustafa S et al (2016) Relapsing optic neuritis and isolated transverse myelitis are the predominant clinical phenotypes for patients with antibodies to myelin oligodendrocyte glycoprotein in India. Mult Scler J Exp Transl Clin 2:2055217316675634","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"8635_CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2008.03834.x","volume":"155","author":"AM Ercolini","year":"2009","unstructured":"Ercolini AM, Miller SD (2009) The role of infections in autoimmune disease. Clin Exp Immunol 155:1\u201315","journal-title":"Clin Exp Immunol"},{"key":"8635_CR43","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1212\/NXI.0000000000000040","volume":"1","author":"S Ramanathan","year":"2014","unstructured":"Ramanathan S, Reddel SW, Henderson A et al (2014) Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis. Neurol Neuroimmunol Neuroinflamm 1:e40","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"8635_CR44","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1177\/1352458515593406","volume":"22","author":"S Ramanathan","year":"2016","unstructured":"Ramanathan S, Prelog K, Barnes EH (2016) Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis. Mult Scler 22:470\u2013482","journal-title":"Mult Scler"},{"key":"8635_CR45","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.autrev.2015.12.004","volume":"15","author":"S Ramanathan","year":"2016","unstructured":"Ramanathan S, Dale RC, Brilot F (2016) Anti-MOG antibody: the history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination. Autoimmun Rev 15:307\u2013324","journal-title":"Autoimmun Rev"},{"key":"8635_CR46","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1212\/NXI.0000000000000131","volume":"2","author":"K Chalmoukou","year":"2015","unstructured":"Chalmoukou K, Alexopoulos H, Akrivou S, Stathopoulos P, Reindl M, Dalakas MC (2015) Anti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritis. Neurol Neuroimmunol Neuroinflamm 2:e131","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"8635_CR47","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1177\/1352458515591071","volume":"22","author":"\u00c1 Cobo-Calvo","year":"2016","unstructured":"Cobo-Calvo \u00c1, Sep\u00falveda M, Bernard-Valnet R, Ruiz A, Brassat D, Mart\u00ednez-Y\u00e9lamos S, Saiz A, Marignier R (2016) Antibodies to myelin oligodendrocyte glycoprotein in aquaporin 4 antibody seronegative longitudinally extensive transverse myelitis: clinical and prognostic implications. Mult Scler 22:312\u2013319","journal-title":"Mult Scler"},{"key":"8635_CR48","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s00415-015-7983-1","volume":"263","author":"L Piccolo","year":"2016","unstructured":"Piccolo L, Woodhall M, Tackley G et al (2016) Isolated new onset \u2018atypical\u2019 optic neuritis in the NMO clinic: serum antibodies, prognoses and diagnoses at follow-up. J Neurol 263:370\u2013379","journal-title":"J Neurol"},{"key":"8635_CR49","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-017-8583-z","author":"\u00c1 Cobo-Calvo","year":"2017","unstructured":"Cobo-Calvo \u00c1, Ruiz A, D\u2019Indy H et al (2017) MOG antibody-related disorders: common features and uncommon presentations. J Neurol. doi:\n                        10.1007\/s00415-017-8583-z","journal-title":"J Neurol"},{"key":"8635_CR50","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2017-315998","author":"JW Hyun","year":"2017","unstructured":"Hyun JW, Woodhall MR, Kim SH et al (2017) Longitudinal analysis of myelin oligodendrocyte glycoprotein antibodies in CNS inflammatory diseases. J Neurol Neurosurg Psychiatry. doi:\n                        10.1136\/jnnp-2017-315998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8635_CR51","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1055\/s-0036-1583184","volume":"47","author":"S Thulasirajah","year":"2016","unstructured":"Thulasirajah S, Pohl D, Davila-Acosta J, Venkateswaran S (2016) Myelin oligodendrocyte glycoprotein-associated pediatric central nervous system demyelination: clinical course, neuroimaging findings, and response to therapy. Neuropediatrics 47:245\u2013252","journal-title":"Neuropediatrics"},{"key":"8635_CR52","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1136\/jnnp-2015-312676","volume":"87","author":"K Kaneko","year":"2016","unstructured":"Kaneko K, Sato DK, Nakashima I et al (2016) Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodies. J Neurol Neurosurg Psychiatry 87:1257\u20131259","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8635_CR53","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1212\/NXI.0000000000000062","volume":"2","author":"SS Zamvil","year":"2015","unstructured":"Zamvil SS, Slavin AJ (2015) Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder? Neurol Neuroimmunol Neuroinflamm 2:e62","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"8635_CR54","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.1212\/NXI.0000000000000163","volume":"2","author":"SM Kim","year":"2015","unstructured":"Kim SM, Woodhall MR, Kim JS (2015) Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS. Neurol Neuroimmunol Neuroinflamm 2:e163","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"8635_CR55","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/brain\/aww350","volume":"140","author":"M Jurynczyk","year":"2017","unstructured":"Jurynczyk M, Geraldes R, Probert F (2017) Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis. Brain 140:617\u2013627","journal-title":"Brain"},{"key":"8635_CR56","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1177\/1352458512470310","volume":"19","author":"K Rost\u00e1sy","year":"2013","unstructured":"Rost\u00e1sy K, Mader S, Hennes EM (2013) Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica. Mult Scler 19:1052\u20131059","journal-title":"Mult Scler"},{"key":"8635_CR57","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1177\/1352458514555785","volume":"21","author":"R H\u00f6ftberger","year":"2015","unstructured":"H\u00f6ftberger R, Sepulveda M, Armangue T (2015) Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease. Mult Scler 21:866\u2013874","journal-title":"Mult Scler"},{"key":"8635_CR58","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1212\/NXI.0000000000000012","volume":"1","author":"RC Dale","year":"2014","unstructured":"Dale RC, Tantsis EM, Merheb V (2014) Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton. Neurol Neuroimmunol Neuroinflamm 1:e12","journal-title":"Neurol Neuroimmunol Neuroinflamm"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-017-8635-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-017-8635-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-017-8635-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T11:27:18Z","timestamp":1589801238000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-017-8635-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,23]]},"references-count":58,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["8635"],"URL":"https:\/\/doi.org\/10.1007\/s00415-017-8635-4","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,23]]}}}